Immunotherapy of immunosenesence; who, how and when?

Open Longevity Science

Volumn 6, Issue , 2012, Pages 56-63

  Govind, Sheila ^a   Lapenna, Antonio ^a   Lang, Pierre Olivier ^a,b   Aspinall, Richard ^a  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Frailty; Healthy ageing; Immunosenescence; Rejuvenation; Reversion

Indexed keywords

GOSERELIN; GROWTH HORMONE; HEPATITIS VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; PNEUMOCOCCUS VACCINE; RECOMBINANT INTERLEUKIN 7; SEX HORMONE; SOMATOMEDIN C;

ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASTRATION; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; COMMUNITY ACQUIRED PNEUMONIA; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; HEPATITIS B; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PHENOTYPIC VARIATION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; TELOMERE HOMEOSTASIS; THYMUS ATROPHY; URINARY TRACT INFECTION; VIRUS IMMUNITY;

EID: 84856858722     PISSN: None     EISSN: 1876326X     Source Type: Journal    
DOI: 10.2174/1876326X01206010056     Document Type: Review

References (79)

1. Kinsella K, He W. An Aging World: 2008. International Population Reports. Washington DC: U.S. Census Bureau June 2009.
2. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science 2002; 296(5570): 1029-31.
3. Heilig GK. IIASA European Rural Development (ERD) project. April 2002.
4. Ostan R, Bucci L, Capri M, et al. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 2008; 15(4-6): 224-40.
5. McElhaney JE. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 2005; 23 (Suppl. 1): S10-25.
6. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103(1-2): 133-8.
7. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32(10): 1481-6.
8. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage pre-dicting mortality and an increased number of dysfunctional cyto-megalovirus-specific T cells in the very elderly. J Immunol 2006; 176(4): 2645-53.
9. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2(11): 659-66.
10. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inac-tivated and live, attenuated influenza vaccines. Scand J Immunol 2004; 59(1): 1-15.
11. Lang PO, Govind S, Mitchell WA, Siegrist CA, Aspinall R. Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience. Ageing Res Rev 2011; 10(3): 389-95.
12. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009; 9(3): 185-94.
13. Monto AS, Ansaldi F, Aspinall R, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009; 27(37): 5043-53.
14. Van Herck K, Leuridan E, Van Damme P. Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and com-pliance. Sex Transm Infect 2007; 83(6): 426-32.
15. Looney RJ, Hasan MS, Coffin D, et al. Hepatitis B immunization of healthy elderly adults: relationship between naive CD4+ T cells and primary immune response and evaluation of GM-CSF as an ad-juvant. J Clin Immunol 2001; 21(1): 30-6.
16. Lang PO, Mitchell WA, Lapenna A, Pitts D, Aspinall R. Immuno-logical pathogenesis of main age-related diseases and frailty: Role of immunosenescence. Eur Geriatr Med 2010; 1(2): 112-21.
17. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984; 28(1): 47-55.
18. Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 2008; 9(5): 299-308.
19. Strindhall J, Nilsson BO, Lofgren S, et al. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 2007; 42(8): 753-61.
20. Wikby A, Ferguson F, Forsey R, et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 2005; 60(5): 556-65.
21. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009; 19(1): 47-56.
22. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev 2007; 65(12 Pt 2): S173-6.
23. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128(1): 92-105.
24. Fulop T, Larbi A, Witkowski JM, et al. Aging, frailty and age-related diseases. Biogerontology 2010; 11(5): 547-63.
25. Aspinall R, Pitts D, Lapenna A, Mitchell W. Immunity in the elderly: the role of the thymus. J Comp Pathol 2010; 142 (Suppl. 1): S111-5.
26. Mitchell WA, Lang PO, Aspinall R. Tracing thymic output in older individuals. Clin Exp Immunol 2010; 161(3): 497-503.
27. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396(6712): 690-5.
28. Aspinall R, Pido J, Andrew D. A simple method for the measurement of sjTREC levels in blood. Mech Ageing Dev 2000; 121(1-3): 59-67.
29. Lang PO, Mitchell WA, Govind S, Aspinall R. Real time-PCR assay estimating the naive T cellpool in whole blood and dried blood spot samples: Pilot study in young adults. J Immunol Methods 2011;369 (1-2): 133-40.
30. Sutherland JS, Goldberg GL, Hammett MV, et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 2005; 175(4): 2741-53.
31. Sutherland JS, Spyroglou L, Muirhead JL, et al. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res 2008; 14(4): 1138-49.
32. Welniak LA, Sun R, Murphy WJ. The role of growth hormone in T cell development and reconstitution. J Leukoc Biol 2002; 71(3): 381-7.
33. Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE. Production of immunoreactive growth hormone by mononucle-ar leukocytes. FASEB J 1988; 2(12): 2812-8.
34. Dardenne M, Mello-Coelho V, Gagnerault MC, Postel-Vinay MC. Growth hormone receptors and immunocompetent cells. Ann N Y Acad Sci 1998; 840: 510-7.
35. Chen BJ, Cui X, Sempowski GD, Chao NJ. Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp Hematol 2003; 31(10): 953-8.
36. Dixit VD, Yang H, Sun Y, et al. Ghrelin promotes thymopoiesis during aging. J Clin Invest 2007; 117(10): 2778-90.
37. Dixit VD, Yang H, Cooper-Jenkins A, Giri BB, Patel K, Taub DD. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood 2009; 113(21): 5202-5.
38. Finch PW, Rubin JS. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithe-lial protection and repair. Adv Cancer Res 2004; 91: 69-136.
39. Erickson M, Morkowski S, Lehar S, et al. Regulation of thymic epithelium by keratinocyte growth factor. Blood 2002; 100(9): 3269-78.
40. Alpdogan O, Hubbard VM, Smith OM, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 2006; 107(6): 2453-60.
41. Kelly RM, Highfill SL, Panoskaltsis-Mortari A, et al. Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T cellreconstitution after murine bone marrow trans-plantation. Blood 2008; 111(12): 5734-44.
42. Turrini P, Zaccaria ML, Aloe L. Presence and possible functional role of nerve growth factor in the thymus. Cell Mol Biol (Noisy-le-grand) 2001; 47(1): 55-64.
43. Jiang Q, Li WQ, Aiello FB, et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005; 16(4-5): 513-33.
44. Andrew D, Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 2002; 37(2-3): 455-63.
45. Andrew D, Aspinall R. Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol 2001; 166(3): 1524-30.
46. Aspinall R, Pido-Lopez J, Imami N, et al. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res 2007; 10(1): 5-17.
47. Rosenberg SA, Sportes C, Ahmadzadeh M, et al. IL-7 administra-tion to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother 2006; 29(3): 313-9.
48. Sportes C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferen-tial expansion of naive T cell subsets. J Exp Med 2008; 205(7): 1701-14.
49. Li L, Hsu HC, Stockard CR, et al. IL-12 inhibits thymic involution by enhancing IL-7-and IL-2-induced thymocyte proliferation. J Immunol 2004; 172(5): 2909-16.
50. Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 2007; 51(4): 301-23.
51. Tian YM, Tian HJ, Zhang GY, Dai YR. Effects of Ginkgo biloba extract (EGb 761) on hydroxyl radical-induced thymocyte apopto-sis and on age-related thymic atrophy and peripheral immune dys-functions in mice. Mech Ageing Dev 2003; 124(8-9): 977-83.
52. Prasad AS. Clinical, endocrinological and biochemical effects of zinc deficiency. Clin Endocrinol Metab 1985; 14(3): 567-89.
53. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 2004; 24: 277-98.
54. Duchateau J, Delepesse G, Vrijens R, Collet H. Beneficial effects of oral zinc supplementation on the immune response of old peo-ple. Am J Med 1981; 70(5): 1001-4.
55. Prasad AS, Meftah S, Abdallah J, et al. Serum thymulin in human zinc deficiency. J Clin Invest 1988; 82(4): 1202-10.
56. Haase H, Rink L. The immune system and the impact of zinc during aging. Immun Ageing 2009; 6: 9.
57. El-Kadiki A, Sutton AJ. Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and metaanalysis of randomised controlled trials. BMJ 2005; 330(7496): 871.
58. Muhlethaler R, Stuck AE, Minder CE, Frey BM. The prognostic significance of protein-energy malnutrition in geriatric patients. Age Ageing 1995; 24(3): 193-7.
59. Lesourd B. Nutrition: a major factor influencing immunity in the elderly. J Nutr Health Aging 2004; 8(1): 28-37.
60. Lesourd B. Nutritional factors and immunological ageing. Proc Nutr Soc 2006; 65(3): 319-25.
61. Cobbold M, Khan N, Pourgheysari B, et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005; 202(3): 379-86.
62. Oelke M, Maus MV, Didiano D, June CH, Mackensen A, Schneck JP. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat Med 2003; 9(5): 619-24.
63. Khan N, Hislop A, Gudgeon N, et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 2004; 173: 7481-9.
64. Trzonkowski P, Mysliwska J, Szmit E, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of antihemagglutinins during the anti-influenza vaccinationan impact of immunosenescence. Vaccine 2003; 21: 3826-36.
65. Wang GC, Kao WHL, Murakami P, et al. Cytomegalovirus Infection and the Risk of Mortality and Frailty in Older Women: A Prospective Observational Cohort Study. Am J Epidemiol 2010; 171(10): 1144-52.
66. Hare KJ, Jenkinson EJ, Anderson G. In vitro models of T cell development. Semin Immunol 1999; 11(1): 3-12.
67. de Pooter RF, Cho SK, Carlyle JR, Zuniga-Pflucker JC. In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors. Blood 2003; 102(5): 1649-53.
68. Lefort N, Benne C, Lelievre JD, et al. Short exposure to Notch ligand Delta-4 is sufficient to induce T cell differentiation program and to increase the T cell potential of primary human CD34+ cells. Exp Hematol 2006; 34(12): 1720-9.
69. Deftos ML, Bevan MJ. Notch signaling in T cell development. Curr Opin Immunol 2000; 12(2): 166-72.
70. La Motte-Mohs RN, Herer E, Zuniga-Pflucker JC. Induction of T celldevelopment from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 2005; 105(4): 1431-9.
71. Clark RA, Yamanaka K, Bai M, Dowgiert R, Kupper TS. Human skin cells support thymus-independent T cell development. J Clin Invest 2005; 115(11): 3239-49.
72. Mera SL. The role of telomeres in ageing and cancer. Br J Biomed Sci 1998; 55: 221-5.
73. Westin ER, Chavez E, Lee KM, et al. Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibro-blasts. Aging Cell 2007; 6: 383-94.
74. Rufer N, Migliaccio M, Antonchuk J, Humphries RK, Roosnek E, Lansdorp PM. Transfer of the human telomerase reverse transcrip-tase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 2001; 98: 597-603.
75. Lang PO, Michel JP, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009; 55(5): 539-49.
76. Rockwood K, Stolee P, McDowell I. Factors associated with institutionalization of older people in Canada: testing a multifacto-rial definition of frailty. J Am Geriatr Soc 1996; 44(5): 578-82.
77. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007; 62(7): 722-7.
78. Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011; 27(1): 17-26.
79. Rockwood K, Mitnitski A. Limits to deficit accumulation in elderly people. Mech Ageing Dev 2006; 127(5): 494-6.